MedTrace Logo

Brain Involvement in Dystrophinopathies Part 2

NCT04668716 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 339

Last updated 2024-07-22

No results posted yet for this study

Summary

The objective of this study is to understand the relationship between DMD and BMD brain comorbidities, and the location of the gene mutation which causes the disease.

Conditions

Sponsors & Collaborators

  • Newcastle-upon-Tyne Hospitals NHS Trust

    collaborator OTHER

  • Leiden University Medical Center

    collaborator OTHER

  • Stichting Kempenhaeghe

    collaborator UNKNOWN

  • Region Hovedstadens Apotek

    collaborator OTHER_GOV

  • Institut Necker Enfants Malades

    collaborator OTHER

  • Catholic University of the Sacred Heart

    collaborator OTHER

  • Università degli Studi di Ferrara

    collaborator OTHER

  • Universidad Complutense de Madrid

    collaborator OTHER

  • Great Ormond Street Hospital for Children NHS Foundation Trust

    lead OTHER

Eligibility

Min Age
5 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-11
Primary Completion
2024-06-30
Completion
2024-06-30

Countries

  • Denmark
  • France
  • Italy
  • Netherlands
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04668716 on ClinicalTrials.gov